A RANDOMISED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF PATHYAGOKSHURADI KWATHA AND TO COMPARE IT WITH SHATAVARYADI KWATHA IN PAITTIKA MUTRAKRICCHRA
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- THE EFFECT OF THE TREATMENT WILL BE ASSESSED BASED ON DETAILED CASE PROFORMA ADOPTING STANDARD SCORING METHODS OF SUBJECTIVE PARAMETERS SUCH AS PAINFUL MICTURITION BURNING MICTURITION DIFFICULTY IN MICTURITION FREQUENCY OF MICTURITION NOCTURIA AND OBJECTIVE PARAMETERS SUCH AS YELLOW COLORATION OF URINE HEMATURIA PUS CELLS/HPF EPITHELIAL CELLS/HPF RBCS/HPF. PRE AND POST INTERVENTIONAL ASSESSMENT WILL BE DONE.
研究概览
简要总结
THIS IS A RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF PATHYAGOKSHURADI KWATHA AND SHATAVARYADI KWATHA IN PAITTIKA MUTRAKRICCHRA FOR DURATION OF 7 DAYS IN 60 PATIENTS IN OPD AND IPD OF PG STUDIES IN KAYACHIKITSA OF ALVAS AYURVEDA MEDICAL COLLEGE AND HOSPITAL MOODBIDRI VIDYAGIRI DAKSHINA KANNADA KARNATAKA INDIA
ASSESSMENT WILL BE DONE BASED ON DETAILED CASE PROFORMA ADOPTING STANDARD SCORING METHODS OF SUBJECTIVE AND OBJECTIVE PARAMETERS
PRE AND POST ASSESSMENT WILL BE DONE CLINICAL SYMPTOMS WILL BE GRADED AND SCORES WILL BE GIVEN ACCORDINGLY
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 16.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patient within the age group of 16-60 years, who will give their written consent, who will agree to follow the protocol of study.
- •Patients with classical symptoms of pittaja mutrakricchra like peeta mutrata, sarakta mutrata, daaha mutrata, rujayukta mutrata and muhur mutrata.
排除标准
- •Paittika mutrakricchra caused due to marmabhighata, due to congenital deformity, due to STD.
- •Vulnerable groups like pregnant women, lactating mother.
- •Patients with other systemic disorders like diabetes mellitus, thyroid disorders, cardiac illness and other disorders which interfere with the treatment.
- •Secondary to disorders like Asthma, BPH, acute renal failure, vesico-ureteric reflux, tumor, renal tuberculosis.
- •Patients who are not willing to consent.
结局指标
主要结局
THE EFFECT OF THE TREATMENT WILL BE ASSESSED BASED ON DETAILED CASE PROFORMA ADOPTING STANDARD SCORING METHODS OF SUBJECTIVE PARAMETERS SUCH AS PAINFUL MICTURITION BURNING MICTURITION DIFFICULTY IN MICTURITION FREQUENCY OF MICTURITION NOCTURIA AND OBJECTIVE PARAMETERS SUCH AS YELLOW COLORATION OF URINE HEMATURIA PUS CELLS/HPF EPITHELIAL CELLS/HPF RBCS/HPF. PRE AND POST INTERVENTIONAL ASSESSMENT WILL BE DONE.
时间窗: AT BASELINE 4TH DAY 8TH DAY AND 15TH DAY
次要结局
未报告次要终点